Welcome to the 47th Annual ESDR Meeting 2017
Concurrent Session 5: Melanoma & Other Skin Cancers
Date: Friday 29 September 2017
Time: 16.10-17.35
Room: Mozart Hall 1-3
Chairs: Andreas Baur, Lionel Larue
Concurrent talks are 8 minutes plus 2 minutes discussion.
Program
16.10-16.20 |
043 (Poster 533) |
16.20-16.30 | 044 (Poster 532) Variable but distinct metabolic signature in malignant melanoma R Lang,1 RG Feichtinger,5 R Geilberger,5 F Rathje,5 JA Mayr,2 W Sperl,2 JW Bauer,1 C Hauser-Kronberger,3 M Emberger4 and B Kofler5 1 Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, Austria, 2 Department of Pediatrics, Paracelsus Medical University Salzburg, Salzburg, Austria, 3 Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria, 4 Laboratory for Pathology Weger/Emberger, Salzburg, Austria and 5 Department of Pediatrics, Research Program for Receptor Biochemistry and Tumor Metabolism, Paracelsus Medical University Salzburg, Salzburg, Austria |
16.30-16.40 | 045 (Poster 522) N-Oct3 is a tumor suppressor and acts as a radioprotector L Larue Institut Curie, Orsay, France |
16.40-16.50 | 046 (Poster 529) Microphthalmia-associated transcription factor regulates dynamic melanoma heterogeneity NK Haass,1,2 L Spoerri,1 CA Tonnessen,1 KA Beaumont,2 DS Hill,2 RJ Jurek,2 SM Daignault,1 F Ahmed,1 AG Smith1 and W Weninger2 1 University of Queensland Diamantina Institute, Woolloongabba, QLD, Australia and 2 Centenary Institute, Sydney, NSW, Australia |
16.50-17.00 | 047 (Poster 538) Transdifferentiation of melanoma cells by the reprogramming factors lose malignant nature in vitro and in vivo M Takaishi and S Sano Dermatology, Kochi Medical School, Nankoku, Japan |
17.00-1710 | 048 (Poster 540) Tumor cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma P Riihilä,1,2 K Viiklepp,1,2 L Nissinen,1,2 M Farshchian,1,2 M Kallajoki,3 A Kivisaari,1,2 S Meri,4 R Grénman,5 S Peltonen,1 J Peltonen6 and V Kähäri1,2 1 Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland, 2 MediCity Research Laboratory, University of Turku, Turku, Finland, 3 Department of Pathology, Turku University Hospital, Turku, Finland, 4 Haartman Institute, University of Helsinki, Helsinki, Finland, 5 Department of Otorhinolaryngology - Head and Neck Surgery, Turku University Hospital, Turku, Finland and 6 Department of Anatomy and Cell Biology, University of Turku, Turku, Finland |
17.10-17.20 | 049 (Poster 537) Accelerated endogenous mutation rate drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa RJ Cho,2 V Atanasova,1 N den Breems,3 L Alexandrov,4 K Tsai5 and A South1 1 Thomas Jefferson University, Philadelphia, PA, 2 UCSF, San Francisco, CA, 3 University of Auckland, Auckland, New Zealand, 4 Los Alamos National Laboratory, Los Alamos, NM and 5 Moffitt Cancer Center, Tampa Bay, FL |
17.20-17.30 | 050 (Poster 528) MicroRNA-130a (miR-130a) regulates self-renewal capacity and tumor growth in cutaneous squamous cell carcinoma W Lohcharoenkal, K Das Mahapatra, N Xu Landén, E Sonkoly and A Pivarcsi Department of Medicine, Unit of Dermatology and Venereology, Karolinska Institutet, Stockholm, Sweden |